Inflammatory bowel disease and osteoporosis

被引:0
|
作者
Ljunghall, S [1 ]
Ljunggren, Ö [1 ]
机构
[1] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden
来源
ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 1999年 / 31卷 / 02期
关键词
bone mineral density; corticosteroids; inflammatory bowel disease; osteoporosis;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with inflammatory bowel disease are at increased risk to develop osteoporosis due to the underlying inflammatory process, as a result of the intestinal dysfunction and as a consequence of the treatment given to counteract the disease. Furthermore, patients with inflammatory bowel disease presumably share with the general population other common risk factors for osteoporosis, e.g. heredity, smoking, inactivity and hormone deficiency. Most recent investigations demonstrate a reduced bone mineral density in inflammatory bowel disease patients, often more apparent in the femoral neck than in the lumbar spine, but there are no controlled fracture studies in these patients. There is , at the bone tissue level, evidence for a negative remodelling balance, i.e., increased resorption with or without suppressed formation and it is commonly found that corticosteroid use significantly contributes to bone loss. Although controlled studies are few, patients with inflammatory bowel disease should be informed about osteoporosis, have their bone mineral density measured and receive general advice including hormone replacement therapy, calcium and vitamin D. In more severe cases antiresorptive therapy might be instituted under close supervision.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [22] Perspectives on osteoporosis in pediatric inflammatory bowel disease
    Manisha Harpavat
    David J. Keljo
    Current Gastroenterology Reports, 2003, 5 (3) : 225 - 232
  • [23] Inflammatory bowel disease and the risk of osteoporosis and fracture
    Targownik, Laura E.
    Bernstein, Charles N.
    Leslie, William D.
    MATURITAS, 2013, 76 (04) : 315 - 319
  • [24] Prevention and treatment of osteoporosis in inflammatory bowel disease
    Lichtenstein, Gary R.
    Sands, Bruce E.
    Pazianas, Michael
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (08) : 797 - 813
  • [25] The Frequency of Osteoporosis Screening in Men With Inflammatory Bowel Disease
    Nguyen, Huy D.
    Bakshi, Anita K.
    Borum, Marie L.
    AMERICAN JOURNAL OF MENS HEALTH, 2010, 4 (01) : 71 - 74
  • [26] Males with Inflammatory Bowel Disease are infrequently screened for osteoporosis
    Nguyen, H.
    Bakshi, A.
    Borum, M.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S36 - S36
  • [27] Prevention and treatment of osteoporosis in patients with inflammatory bowel disease
    Valentine, JF
    Sninsky, CA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (04): : 878 - 883
  • [28] Osteoporosis Screening in a Tertiary Referral - Inflammatory Bowel Disease
    Kaufman, Lia
    Loftus, Edward
    Sandborn, William
    Kammer, Patricia
    Pardi, Darrell
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S476 - S476
  • [29] Osteoporosis in newly diagnosed inflammatory bowel disease -: Reply
    Schoon, EJ
    Russel, MGVM
    Stockbrügger, RW
    GASTROENTEROLOGY, 2001, 121 (02) : 505 - 506
  • [30] OSTEOPOROSIS RISK FACTORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Nassar, K.
    Janani, S.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S148 - S149